tiprankstipranks
Xencor doses first subject in first-in-human study of XmAb942
PremiumThe FlyXencor doses first subject in first-in-human study of XmAb942
2M ago
Is XNCR a Buy, Before Earnings?
Premium
Pre-Earnings
Is XNCR a Buy, Before Earnings?
2M ago
Xencor Board Member Dagmar Rosa-Bjorkeson to Step Down
Premium
Company Announcements
Xencor Board Member Dagmar Rosa-Bjorkeson to Step Down
3M ago
Xencor jumps after announcing four new XmAb programs
PremiumThe FlyXencor jumps after announcing four new XmAb programs
3M ago
Xencor Reports Progress in Oncology and Autoimmune Therapies
Premium
Company Announcements
Xencor Reports Progress in Oncology and Autoimmune Therapies
3M ago
Xencor reports Q2 EPS ($1.07), consensus (88c)
Premium
The Fly
Xencor reports Q2 EPS ($1.07), consensus (88c)
5M ago
Xencor price target raised to $36 from $34 at Wedbush
PremiumThe FlyXencor price target raised to $36 from $34 at Wedbush
8M ago
Xencor reports Q1 EPS ($1.11), consensus (79c)
Premium
The Fly
Xencor reports Q1 EPS ($1.11), consensus (79c)
8M ago
XNCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
XNCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100